Literature DB >> 24698429

Visual system integrity and cognition in early Huntington's disease.

Robert C Wolf1, Fabio Sambataro, Nenad Vasic, Eva-Maria Baldas, Iris Ratheiser, Georg Bernhard Landwehrmeyer, Malte S Depping, Philipp A Thomann, Reiner Sprengelmeyer, Sigurd D Süssmuth, Michael Orth.   

Abstract

Posterior cortical volume changes and abnormal visuomotor performance are present in patients with Huntington's disease (HD). However, it is unclear whether posterior cortical volume loss contributes to abnormal neural activity, and whether activity changes predict cognitive dysfunction. Using magnetic resonance imaging (MRI), we investigated brain structure and visual network activity at rest in patients with early HD (n = 20) and healthy controls (n = 20). The symbol digit modalities test (SDMT) and subtests of the Visual Object and Space Perception Battery were completed offline. For functional MRI data, a group independent component analysis was used. Voxel-based morphometry was employed to assess regional brain atrophy, and 'biological parametric mapping' analyses were included to investigate the impact of atrophy on neural activity. Patients showed significantly worse visuomotor and visual object performance than controls. Structural analyses confirmed occipitotemporal atrophy. In patients and controls, two spatiotemporally distinct visual systems were identified. Patients showed decreased activity in the left fusiform cortex, and increased left cerebellar activity. These findings remained stable after correction for brain atrophy. Lower fusiform cortex activity was associated with lower SDMT performance and with higher disease burden scores. These associations were absent when cerebellar function was related to task performance and disease burden. The results of this study suggest that regionally specific functional abnormalities of the visual system can account for the worse visuomotor cognition in HD patients. However, occipital volume changes cannot sufficiently explain abnormal neural function in these patients.
© 2014 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  independent component analysis; magnetic resonance imaging; occipital cortex; resting state

Mesh:

Year:  2014        PMID: 24698429     DOI: 10.1111/ejn.12575

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  17 in total

1.  Triheptanoin improves brain energy metabolism in patients with Huntington disease.

Authors:  Isaac Mawusi Adanyeguh; Daisy Rinaldi; Pierre-Gilles Henry; Samantha Caillet; Romain Valabregue; Alexandra Durr; Fanny Mochel
Journal:  Neurology       Date:  2015-01-07       Impact factor: 9.910

2.  Impact of Visual Corticostriatal Loop Disruption on Neural Processing within the Parahippocampal Place Area.

Authors:  Shahin Nasr; Herminia D Rosas
Journal:  J Neurosci       Date:  2016-10-05       Impact factor: 6.167

3.  Baseline brain perfusion and brain structure in patients with major depression: a multimodal magnetic resonance imaging study.

Authors:  Nenad Vasic; Nadine D Wolf; Georg Grön; Zrinka Sosic-Vasic; Bernhard J Connemann; Fabio Sambataro; Anna von Strombeck; Dirk Lang; Stefanie Otte; Manuela Dudek; Robert C Wolf
Journal:  J Psychiatry Neurosci       Date:  2015-11       Impact factor: 6.186

4.  Impact of Huntington's Disease on Mental Rotation Performance in Motor Pre-Symptomatic Individuals.

Authors:  Shahin Nasr; Herminia D Rosas
Journal:  J Huntingtons Dis       Date:  2019

5.  Brain, cognitive, and physical disability correlates of decreased quality of life in patients with Huntington's disease.

Authors:  Estefanía Junca; Mariana Pino; Hernando Santamaría-García; Sandra Baez
Journal:  Qual Life Res       Date:  2022-08-17       Impact factor: 3.440

6.  Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease.

Authors:  Lora Minkova; Sarah Gregory; Rachael I Scahill; Ahmed Abdulkadir; Christoph P Kaller; Jessica Peter; Jeffrey D Long; Julie C Stout; Ralf Reilmann; Raymund A Roos; Alexandra Durr; Blair R Leavitt; Sarah J Tabrizi; Stefan Klöppel
Journal:  Neuroimage Clin       Date:  2017-10-25       Impact factor: 4.881

7.  Genetics Modulate Gray Matter Variation Beyond Disease Burden in Prodromal Huntington's Disease.

Authors:  Jingyu Liu; Jennifer Ciarochi; Vince D Calhoun; Jane S Paulsen; H Jeremy Bockholt; Hans J Johnson; Jeffrey D Long; Dongdong Lin; Flor A Espinoza; Maria B Misiura; Arvind Caprihan; Jessica A Turner
Journal:  Front Neurol       Date:  2018-03-29       Impact factor: 4.003

8.  Recommendations for the Use of Automated Gray Matter Segmentation Tools: Evidence from Huntington's Disease.

Authors:  Eileanoir B Johnson; Sarah Gregory; Hans J Johnson; Alexandra Durr; Blair R Leavitt; Raymund A Roos; Geraint Rees; Sarah J Tabrizi; Rachael I Scahill
Journal:  Front Neurol       Date:  2017-10-10       Impact factor: 4.003

9.  Neurofilament light protein in blood predicts regional atrophy in Huntington disease.

Authors:  Eileanoir B Johnson; Lauren M Byrne; Sarah Gregory; Filipe B Rodrigues; Kaj Blennow; Alexandra Durr; Blair R Leavitt; Raymund A Roos; Henrik Zetterberg; Sarah J Tabrizi; Rachael I Scahill; Edward J Wild
Journal:  Neurology       Date:  2018-01-24       Impact factor: 9.910

10.  HttQ111/+ Huntington's Disease Knock-in Mice Exhibit Brain Region-Specific Morphological Changes and Synaptic Dysfunction.

Authors:  Marina Kovalenko; Austen Milnerwood; James Giordano; Jason St Claire; Jolene R Guide; Mary Stromberg; Tammy Gillis; Ellen Sapp; Marian DiFiglia; Marcy E MacDonald; Jeffrey B Carroll; Jong-Min Lee; Susan Tappan; Lynn Raymond; Vanessa C Wheeler
Journal:  J Huntingtons Dis       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.